Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 86,000 shares at $207.23 ($18.0M) on 2026-08-21, disclosed to the SEC on 2026-08-25.
Scheduled sale ($18.0M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $207.23 | 5,128 | $1.1M | 5.9% |
| 2 | $207.25 | 190 | $39K | 0.2% |
| 3 | $207.25 | 177 | $37K | 0.2% |
| 4 | $208.36 | 937 | $195K | 1.1% |
| 5 | $208.36 | 951 | $198K | 1.1% |
| 6 | $208.37 | 24,917 |
| $5.2M |
| 28.9% |
| 7 | $209.26 | 35,938 | $7.5M | 41.8% |
| 8 | $209.27 | 1,405 | $294K | 1.6% |
| 9 | $209.28 | 1,351 | $283K | 1.6% |
| 10 | $210.25 | 3,813 | $802K | 4.5% |
| 11 | $210.40 | 136 | $29K | 0.2% |
| 12 | $210.40 | 126 | $27K | 0.1% |
| 13 | $211.33 | 6,583 | $1.4M | 7.7% |
| 14 | $211.46 | 229 | $48K | 0.3% |
| 15 | $211.47 | 245 | $52K | 0.3% |
| 16 | $212.06 | 127 | $27K | 0.1% |
| 17 | $212.06 | 126 | $27K | 0.1% |
| 18 | $212.08 | 3,621 | $768K | 4.3% |
| Total | $209.20 avg | 86,000 | $18.0M | 100% |
| Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |
| RVMD | SELL | 2026-03-03 | $7.2M | — | Filing → |